These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 9658145)

  • 21. Transcriptional activation of the tat-defective human immunodeficiency virus type-1 provirus: effect of interferon.
    Popik W; Pitha PM
    Virology; 1992 Aug; 189(2):435-47. PubMed ID: 1641975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of HIV-1 gene expression.
    Cullen BR
    FASEB J; 1991 Jul; 5(10):2361-8. PubMed ID: 1712325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions of thyroid hormone receptor with the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and the HIV-1 Tat transactivator.
    Desai-Yajnik V; Hadzic E; Modlinger P; Malhotra S; Gechlik G; Samuels HH
    J Virol; 1995 Aug; 69(8):5103-12. PubMed ID: 7609079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absolute dependence on kappa B responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes.
    Alcamí J; Laín de Lera T; Folgueira L; Pedraza MA; Jacqué JM; Bachelerie F; Noriega AR; Hay RT; Harrich D; Gaynor RB
    EMBO J; 1995 Apr; 14(7):1552-60. PubMed ID: 7729429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of the human immunodeficiency virus type 1 long terminal repeat by BTEB, a GC box-binding transcription factor.
    Imataka H; Mizuno A; Fujii-Kuriyama Y; Hayami M
    AIDS Res Hum Retroviruses; 1993 Sep; 9(9):825-31. PubMed ID: 8257632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The human immunodeficiency virus long terminal repeat includes a specialised initiator element which is required for Tat-responsive transcription.
    Rittner K; Churcher MJ; Gait MJ; Karn J
    J Mol Biol; 1995 May; 248(3):562-80. PubMed ID: 7752225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding of NF-kB to the HIV-1 LTR is not sufficient to induce HIV-1 LTR activity.
    Doppler C; Schalasta G; Amtmann E; Sauer G
    AIDS Res Hum Retroviruses; 1992 Feb; 8(2):245-52. PubMed ID: 1540410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional similarities between HIV-1 Tat and DNA sequence-specific transcriptional activators.
    Madore SJ; Cullen BR
    Virology; 1995 Feb; 206(2):1150-4. PubMed ID: 7856090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NUCKS1, a novel Tat coactivator, plays a crucial role in HIV-1 replication by increasing Tat-mediated viral transcription on the HIV-1 LTR promoter.
    Kim HY; Choi BS; Kim SS; Roh TY; Park J; Yoon CH
    Retrovirology; 2014 Aug; 11():67. PubMed ID: 25116364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA.
    Kashanchi F; Shibata R; Ross EK; Brady JN; Martin MA
    J Virol; 1994 May; 68(5):3298-307. PubMed ID: 8151790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A CNS-enriched factor that binds to NF-kappa B and is required for interaction with HIV-1 tat.
    Taylor JP; Pomerantz RJ; Oakes JW; Khalili K; Amini S
    Oncogene; 1995 Jan; 10(2):395-400. PubMed ID: 7838536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The RNA element encoded by the trans-activation-responsive region of human immunodeficiency virus type 1 is functional when displaced downstream of the start of transcription.
    Churcher MJ; Lowe AD; Gait MJ; Karn J
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2408-12. PubMed ID: 7892280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox state.
    Westendorp MO; Shatrov VA; Schulze-Osthoff K; Frank R; Kraft M; Los M; Krammer PH; Dröge W; Lehmann V
    EMBO J; 1995 Feb; 14(3):546-54. PubMed ID: 7859743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The human immunodeficiency virus type 1 Tat protein transactivates tumor necrosis factor beta gene expression through a TAR-like structure.
    Buonaguro L; Buonaguro FM; Giraldo G; Ensoli B
    J Virol; 1994 Apr; 68(4):2677-82. PubMed ID: 8139045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human chromosome 12 is required for optimal interactions between Tat and TAR of human immunodeficiency virus type 1 in rodent cells.
    Alonso A; Derse D; Peterlin BM
    J Virol; 1992 Jul; 66(7):4617-21. PubMed ID: 1602563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential role of long terminal repeat control elements for the regulation of basal and Tat-mediated transcription of the human immunodeficiency virus in stimulated and unstimulated primary human macrophages.
    Moses AV; Ibanez C; Gaynor R; Ghazal P; Nelson JA
    J Virol; 1994 Jan; 68(1):298-307. PubMed ID: 8254741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat.
    Berkhout B; Jeang KT
    J Virol; 1992 Jan; 66(1):139-49. PubMed ID: 1727476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity.
    Hammarskjöld ML; Simurda MC
    J Virol; 1992 Nov; 66(11):6496-501. PubMed ID: 1404600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of Tat function in human immunodeficiency virus type 1-infected low-level-expression cell lines U1 and ACH-2.
    Cannon P; Kim SH; Ulich C; Kim S
    J Virol; 1994 Mar; 68(3):1993-7. PubMed ID: 8107261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells.
    Westendorp MO; Li-Weber M; Frank RW; Krammer PH
    J Virol; 1994 Jul; 68(7):4177-85. PubMed ID: 8207793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.